YBX1 and triple-negative breast carcinoma: In addition, the overexpression of piR-YBX1 can inhibit the binding of YBX1 to RAF1, a key molecule in the MAPK signaling pathway, and then inhibit p-MEK and p-ERK1/2, and inhibit the proliferation and metastasis of triple-negative breast cancer (109).